Navigation Links
Allergen, Drugs, Penicillin G (major)

ProductsAllergen, Drugs, Penicillin G (major)
Company ARUP Laboratories
Item Allergen, Drugs, Penicillin G (major)
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Allergen, Drugs, Amoxicillin
2. Allergen, Drugs, Ampicillin
3. Allergen, Drugs, Penicillin V (minor)
4. Allergen, Epidermals & Animal Proteins,Budgerigar Droppings (Parakeet)
5. Allergen, Epidermals & Animal Proteins, Aust Parrot Droppings
6. Allergen, Epidermals & Animal Proteins,Chicken Feathers
7. Allergen, Epidermals & Animal Proteins, Cat Epithelium & Dander
8. Allergen, Epidermals & Animal Proteins, Cow Hair & Dander
9. Allergen, Epidermals & Animal Proteins, Dog Dander
10. Allergen, Epidermals & Animal Proteins, Dog Epithelium
11. Allergen, Epidermals & Animal Proteins, Goat Epithelium
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces.
For accurately monitoring core temperature and heart and breath sounds as well as for gastric suctioning.
For accurately monitoring core temperature and heart and breath sounds.
...se of a heartbeat. The bodys warmth beneath drapes...se vital signs are yours to guard, measure, stabil...Monitoring products helps you do your job, giving ...fortable and precise management of your patients s...
Medicine Products:
(Date:9/5/2008)...5 /PRNewswire/ -- Arthrosurface, Inc.,( http://www...ve joint,resurfacing systems, announced that it ha... pivotal investigation for its line of focal knee,...re no outstanding safety,concerns" with the device... has been evaluating the safety and efficacy of it...
(Date:9/5/2008)...5 /PRNewswire/ -- On Saturday, September 6, PARI,R...n Network show Today,s,Family as part of their "Br...ding medical device company that provides patients...s and compressors that deliver needed,medications ... the lives of those affected by respiratory,diseas...
(Date:9/5/2008)...t for those overweight or obese at age 45 , ...alf of all American adults will develop osteoarthr...e if they are obese in middle age, a new study say...dition increased as his or her body-mass index (BM...lina at Chapel Hill study. People who were of norm...
(Date:9/5/2008)...k prediction models are enhanced by taking into ac...pair capacity, according to research teams led by ...nderson Cancer Center in two complementary papers ...tion Research . , In the first study to focus on...ts based on increased exposure to certain risks. B...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3
... in Romania have confirmed the presence of new H5N...ird flu infection in Ostrov // (near the Bulgarian...fected by bird flu. Laboratory examination done o...n confirmed to be positive for bird flu infection....
...hat complex regional pain syndrome is a neurologic...cting small fibers which has the ability to sense ...atic limb pain and other disturbances that continu...ealed. But the causes of the symptoms of the syndr...
...rchers say that they have formulated a combination... It was believed for a long time that new borns di...laid to rest by stringent research. The problem wa...g the basic constitution of infants. Principal i...
... a lesser risk of Parkinson’s, according to novel ...urosurgery and Psychiatry. // The research team, ...06 Parkinson’s patients and 106 healthy people, be...roups’ responded to questions that sought to throw...
Other Medicine News:
(Date:9/4/2008)... Practice Bulletin for Obstetrician-Gynecologists ...ctice Change-Minimally Invasive Interventional,Rad...en With Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /...ional Radiology, a national organization of nearly...ssionals dedicated to improving health,care throug...
(Date:9/4/2008)...votal Study Seeks to Enroll 750 Women at More Than... /- QuatRx Pharmaceuticals, a,private...opment and,commercialization of compounds to treat..., today announced that it has initiated a second,P...blets), the company,s,estrogen-free oral therapy i...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to b...-FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) anno...mumab,an investigational anti-CTLA-4 antibody, in...ntations at the 33rd Congress of the European Soci...er 12-16, 2008 in Stockholm.,Many of the following...
(Date:9/4/2008)... Optimizing Patient Identification for Tar...of Personalized Treatment HUNTINGTON BEACH, Cal...re/ -- Agendia, a world leader in molecular cancer...Print(R), a new diagnostic test that,allows physic...on levels of,the estrogen receptor (ER), progester...
Breaking Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3908 1Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3908 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3908 3Four Rivers Software Systems and ECRI Institute Announce New Real Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall 14154 1Four Rivers Software Systems and ECRI Institute Announce New Real Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall 14154 2Four Rivers Software Systems and ECRI Institute Announce New Real Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall 14154 3MHA to Release Findings of Independent Long Term Care Member Study 14150 1MHA to Release Findings of Independent Long Term Care Member Study 14150 2To bet or not to bet 3A How the brain learns to estimate risk 14146 1To bet or not to bet 3A How the brain learns to estimate risk 14146 2
...ron Corporation notified the CDC that none of its ...r distribution in the United States for the curren...oval of nearly half of the anticipated American va...blic have grown increasingly alarmed about the sca...c. , ,It remains to be seen if virulent new st...
...he recent proliferation of rapid, easy-to-use diag...have entered the marketplace to help clinicians as...nd to screen for the presence of drugs of abuse. S...hile many simple test kits are suitable for point ...and workplace use. , , Therapeutic drug monito...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4